We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$636M
Cap. Flow %
-11.06%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170

Top Buys

Rank Stock Value
1
CFN
CAREFUSION CORPORATION
CFN
+$125M
2
CVD
COVANCE INC.
CVD
+$75.9M
3
AGN
Allergan Inc
AGN
+$71.6M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$69.7M
5
PEP icon
PepsiCo
PEP
+$52.7M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Healthcare 11.85%
2 Consumer Discretionary 11.63%
3 Consumer Staples 10.69%
4 Industrials 10.3%
5 Technology 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMX icon
626
CarMax
KMX
$8.28B
– –
-183,647
Closed -$8.53M
KSS icon
627
PUT
Kohl's
KSS
$2.08B
– –
-100,000
Closed -$25K
LPX icon
628
Louisiana-Pacific
LPX
$5.48B
– –
-447,993
Closed -$6.09M
LSCC icon
629
Lattice Semiconductor
LSCC
$19B
– –
-11,146
Closed -$84K
LTC
630
LTC Properties
LTC
$2.13B
– –
-5,774
Closed -$213K
LULU icon
631
CALL
lululemon athletica
LULU
$14.3B
– –
-103,500
Closed -$45K
LULU icon
632
lululemon athletica
LULU
$14.3B
– –
-26,285
Closed -$1.1M
LUMN icon
633
Lumen
LUMN
$6.41B
– –
-45,916
Closed -$1.88M
MATX icon
634
Matsons
MATX
$6.18B
– –
-143,000
Closed -$3.58M
MCD icon
635
McDonald's
MCD
$196B
– –
-2,266
Closed -$215K
MDLZ icon
636
CALL
Mondelez International
MDLZ
$80.1B
– –
-50,000
Closed -$2K
MET icon
637
MetLife
MET
$62.6B
– –
-253,430
Closed -$12.1M
MFIC icon
638
MidCap Financial Investment
MFIC
$797M
– –
-13,237
Closed -$324K
MGM icon
639
MGM Resorts International
MGM
$11.2B
– –
-48,751
Closed -$1.11M
MT icon
640
ArcelorMittal
MT
$54.7B
– –
-484,903
Closed -$15.2M
NBIX icon
641
Neurocrine Biosciences
NBIX
$16.7B
– –
-100,000
Closed -$1.57M
NRG icon
642
NRG Energy
NRG
$25.3B
– –
-254,010
Closed -$7.74M
NUWE icon
643
Nuwellis
NUWE
$565K
– –
0
– -$88K
OC icon
644
Owens Corning
OC
$12.3B
– –
-108,565
Closed -$3.45M
OSK icon
645
Oshkosh
OSK
$9.6B
– –
-265,951
Closed -$11.7M
PBR icon
646
Petrobras
PBR
$119B
– –
-35,100
Closed -$498K
PEG icon
647
CALL
Public Service Enterprise Group
PEG
$37.4B
– –
-50,000
Closed -$4K
PLD icon
648
Prologis
PLD
$133B
– –
-81,440
Closed -$3.07M
PM icon
649
Philip Morris
PM
$293B
– –
-228,053
Closed -$19M
PRTA icon
650
Prothena Corp
PRTA
$447M
– –
-35,000
Closed -$776K
24 25
26
27 28

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.